HOUSTON, TX / ACCESS Newswire / March 4, 2026 / BrYet US, Inc. ("BrYet") - a biotechnology innovator focused on developing curative therapies for advanced cancers - announced today that it has filed ...

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Currently, no consensus exists regarding the definition of oligometastatic pancreatic ductal adenocarcinoma, its necessary diagnostic measures, and potential treatment approaches. To address these ...

A protein, the farnesoid X receptor, that is a key modulator of fat, glucose and cholesterol levels in the body usually works in tandem with another protein, but new research shows it can also work ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...

The hourlong program “Why Can’t We Cure Cancer? A National Conversation” comes as a follow-up to NewsNation’s November ...

A new study suggests that even modest amounts of this carbonated beverage may be associated with higher rates of metabolic fatty liver disease. A new study, published in the Annals of Hepatology, ...